The global Central Lab Services/Clinical Trial Lab Services Market, valued at US$5.64 billion in 2024, is forecasted to grow at a robust CAGR ...

A lesser-known island bought by the seventh richest man on the planet has no public transport or traffic lights and is a ...

The global clinical trials market has emerged as a vital cornerstone of the healthcare sector, driven by an ever-increasing ...

Kent Lake PR LLC (“Kent Lake”), a holder of 6.9% of the outstanding common stock of Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX ...

Mainz Biomed (MYNZ) announced it has entered into a License and Option Agreement with Liquid Biosciences to access a portfolio of novel mRNA ...

Discovery Analysis Demonstrates Transformative Sensitivity of 95% with Specificity of 98% for the Detection of Pancreatic Cancer in Blood ...

Once daily treatment with Denali's oral candidate DNL343 failed to reduce NfL levels in adults with ALS in the HEALEY trial.

Columnist Dagmar Munn says she has often felt out of place in the ALS community because of the slower pace of her disease ...

The 15 th World Clinical Biomarkers & Companion Diagnostics Summit Europe, held in London from April 8 th to 10 th, aims to address common concerns among European Biomarker, Translational ...

Study finds antibodies that target Epstein-Barr virus proteins can also attack proteins in the brain, increasing the ...

Tolebrutinib is more effective in reducing the risk of disability progression in MS patients with paramagnetic rim lesions, ...